Ajugamarin G 1 exhibits significant anti-inflammatory activity by inhibiting the production of nitric oxide (NO) in lipopolysaccharide (LPS)-stimulated microglial cells. This property makes it a potential candidate for research into neurodegenerative diseases where neuroinflammation plays a key role, such as Alzheimer's and Parkinson’s disease. It also shows moderate cytotoxic effects against certain cancer cell lines, suggesting possible utility in anticancer drug development. Additionally, due to its origin in medicinal plants of the Ajuga genus, it contributes to the pharmacological profile of traditional herbal remedies used for treating inflammatory and infectious conditions.